Trump’s FDA pick is no CBD expert
Little is expected to change at the US FDA in terms of CBD or cannabis policy if president Donald Trump’s nominee Stephen Hahn is approved as commissioner, according to sources contacted by CBD-Intel
Discover our platform
Business briefing
‘Potential goes beyond CBD and THC – but consumers need educating’
12th November 2019
Regulatory briefing
Portugal steps up enforcement over edibles with seizure in Porto
13th November 2019